Great Lakes Advisors LLC Lowers Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Great Lakes Advisors LLC trimmed its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 0.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 353,008 shares of the healthcare conglomerate's stock after selling 1,202 shares during the period. UnitedHealth Group comprises about 1.5% of Great Lakes Advisors LLC's investment portfolio, making the stock its 4th largest position. Great Lakes Advisors LLC's holdings in UnitedHealth Group were worth $178,573,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently bought and sold shares of the company. NewSquare Capital LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter valued at $25,000. AlphaMark Advisors LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter valued at $30,000. Promus Capital LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter valued at $32,000. RPg Family Wealth Advisory LLC bought a new stake in UnitedHealth Group in the third quarter valued at about $37,000. Finally, Pillar Financial Advisors LLC bought a new stake in UnitedHealth Group in the fourth quarter valued at about $40,000. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Stock Performance

Shares of UNH opened at $486.54 on Wednesday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The stock has a 50 day moving average price of $512.82 and a two-hundred day moving average price of $552.00. The firm has a market capitalization of $445.04 billion, a P/E ratio of 31.39, a P/E/G ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73.

Remove Ads

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group's quarterly revenue was up 6.8% on a year-over-year basis. During the same period in the prior year, the company posted $5.83 earnings per share. Equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th will be paid a dividend of $2.10 per share. The ex-dividend date is Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.73%. UnitedHealth Group's dividend payout ratio (DPR) is currently 54.19%.

Analyst Upgrades and Downgrades

UNH has been the subject of several recent analyst reports. KeyCorp restated an "overweight" rating and issued a $650.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. HSBC upgraded UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price target for the company in a report on Friday, January 10th. Hsbc Global Res upgraded UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a report on Friday, January 10th. Piper Sandler decreased their price objective on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a report on Thursday, January 2nd. Finally, Deutsche Bank Aktiengesellschaft increased their price target on UnitedHealth Group from $595.00 to $625.00 and gave the company a "buy" rating in a research report on Tuesday, December 3rd. One equities research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Buy" and an average price target of $629.32.

Insider Activity

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now owns 4,500 shares of the company's stock, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.33% of the company's stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.